In the current study, 42.0% of the individuals had not previously experienced COVID-19 symptoms, and there were anti-SARS-CoV-2 IgM- and IgG-positive cases among them, with a prevalence of 13.1% and 33.3%, respectively. This evidence concerns the gene CD40LG and COVID-19.